PRECIPIO, INC. (PRPO) Gross Margin
- Gross margin · 12 months: Value 43.33%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 43.33% | Gross profit / revenue. Period ending 2026-06-30. $12.00M ÷ $27.69M × 100 ≈ 43.33% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 12.00M USD | Gross Profit |
| Revenue | 27.69M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 15.20M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $12.00M | $27.69M | $15.20M | 43.33% |
| 2026-03-31 | $11.29M | $26.30M | $14.54M | 42.94% |
| 2025-12-31 | $10.71M | $24.25M | $13.34M | 44.16% |
| 2025-09-30 | $10.22M | $22.74M | $12.58M | 44.95% |
| 2025-06-30 | $9.49M | $21.13M | $11.75M | 44.92% |
| 2025-03-31 | $8.78M | $20.01M | $11.25M | 43.88% |
| 2024-12-31 | $7.56M | $18.58M | $10.97M | 40.69% |
| 2024-09-30 | $6.93M | $17.64M | $10.48M | 39.27% |
| 2024-06-30 | $6.53M | $16.93M | $10.19M | 38.60% |
| 2024-03-31 | $6.19M | $16.06M | $9.62M | 38.53% |
| 2023-12-31 | $6.02M | $15.41M | $9.18M | 39.04% |
| 2023-09-30 | $4.60M | $13.60M | $8.66M | 33.86% |
| 2023-06-30 | $3.15M | $11.32M | $7.80M | 27.86% |
| 2023-03-31 | $2.56M | $10.12M | $7.23M | 25.25% |
| 2022-12-31 | $2.51M | $9.82M | $6.90M | 25.56% |
| 2022-09-30 | $2.56M | $9.47M | $6.90M | 27.00% |
| 2022-06-30 | $2.65M | $9.31M | $6.84M | 28.44% |
| 2022-03-31 | $2.63M | $9.11M | $6.84M | 28.83% |
| 2021-12-31 | $2.39M | $8.70M | $6.46M | 27.50% |
| 2021-09-30 | $2.22M | $8.75M | $6.13M | 25.42% |
| 2021-06-30 | $2.07M | $8.66M | $5.66M | 23.94% |
| 2021-03-31 | $1.49M | $8.06M | $5.21M | 18.52% |
| 2020-12-31 | $1.15M | $7.43M | $4.94M | 15.48% |
| 2020-09-30 | $654.00K | $6.11M | $4.18M | 10.71% |
| 2020-06-30 | $305.00K | $5.11M | $3.69M | 5.97% |
| 2020-03-31 | $306.00K | $4.66M | $3.32M | 6.57% |
| 2019-12-31 | $219.00K | $4.09M | $2.91M | 5.35% |
| 2019-09-30 | $275.00K | $4.03M | $2.85M | 6.82% |
| 2019-06-30 | $236.00K | $3.81M | $2.75M | 6.20% |
| 2019-03-31 | $239.00K | $3.57M | $2.63M | 6.70% |
| 2018-12-31 | $225.00K | $3.45M | $2.64M | 6.53% |
| 2018-09-30 | $515.00K | $3.12M | $2.61M | 16.49% |
| 2018-06-30 | $449.00K | $2.74M | $2.29M | 16.36% |
| 2018-03-31 | $250.00K | (m) | $1.94M | (m) |
| 2017-12-31 | $292.00K | $1.72M | $1.43M | 16.95% |
| 2017-09-30 | $-937.00K | (m) | $1.86M | (m) |
| 2017-06-30 | $-726.00K | (m) | $1.75M | (m) |
| 2017-03-31 | $263.00K | $1.98M | $1.72M | 13.29% |
| 2016-12-31 | $-205.00K | $1.56M | $1.76M | -13.17% |
| 2016-09-30 | $-713.00K | $1.33M | $2.04M | -53.65% |
| 2016-06-30 | $-855.00K | $1.20M | $2.06M | -71.13% |
| 2016-03-31 | $-841.00K | $1.14M | $1.98M | -73.84% |
| 2015-12-31 | $-287.00K | $1.65M | $1.94M | -17.36% |
| 2015-09-30 | $11.96M | $29.16M | $17.20M | 41.00% |
| 2015-06-30 | $10.68M | $27.62M | $16.94M | 38.67% |
| 2015-03-31 | $10.20M | $27.34M | $17.14M | 37.30% |
| 2014-12-31 | $9.72M | $27.08M | $17.36M | 35.89% |
| 2014-09-30 | $10.92M | $25.61M | $14.69M | 42.65% |
| 2014-06-30 | $11.15M | $25.88M | $14.72M | 43.10% |
| 2014-03-31 | $11.73M | $26.42M | $14.69M | 44.42% |
| 2013-12-31 | $12.50M | $27.54M | $15.05M | 45.37% |
| 2013-09-30 | $13.49M | $28.62M | $15.13M | 47.12% |
| 2013-06-30 | $14.44M | $29.86M | $15.43M | 48.34% |
| 2013-03-31 | $15.59M | $31.65M | $16.06M | 49.25% |
| 2012-12-31 | $15.01M | $31.48M | $16.47M | 47.68% |
| 2012-09-30 | $16.75M | $32.76M | $16.01M | 51.13% |
| 2012-06-30 | $17.36M | $33.12M | $15.76M | 52.42% |
| 2012-03-31 | $17.39M | $31.70M | $14.31M | 54.85% |
| 2011-12-31 | $18.44M | $31.97M | $13.53M | 57.67% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $9.76M | $20.05M | $10.28M | 48.70% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $11.61M | $22.02M | $10.42M | 52.69% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |